Floatz logo

DEXAMETHASONE

NK-Cell Leukemia

New York Medical CollegeSmall moleculeEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

18 Active assets in the NK-Cell Leukemia cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
The Affiliated Hospital of Xuzhou Medical University
Phase 2B
Anti-Thymoglobulin, Rabbit
St. Jude Children's Research Hospital
Phase 2CCC
Mesna
St. Jude Children's Research Hospital
Phase 2CCC
Thiotepa
St. Jude Children's Research Hospital
Phase 2CCC
Anti-Cd56 Car T
The Affiliated Hospital of Xuzhou Medical University
Phase 2CCC

View all 21 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →